Cabralealactone is primarily studied for its potential anticancer properties. It has shown inhibitory effects on the growth of various cancer cell lines, particularly through the induction of apoptosis and suppression of tumor proliferation pathways. Research indicates it may target signaling pathways such as NF-κB and STAT3, which are involved in inflammation and cancer progression. Due to its natural origin and bioactive profile, it is considered a lead compound in the development of novel chemotherapeutic agents. Additionally, it exhibits antioxidant and anti-inflammatory activities, suggesting possible applications in treating chronic diseases linked to oxidative stress and inflammation. However, its use remains largely in the preclinical research stage.